Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Differentiation between oligodendroglioma genotypes using dynamic susceptibility contrast perfusion-weighted imaging and proton MR spectroscopy.

Chawla S, Krejza J, Vossough A, Zhang Y, Kapoor GS, Wang S, O'Rourke DM, Melhem ER, Poptani H.

AJNR Am J Neuroradiol. 2013 Aug;34(8):1542-9. doi: 10.3174/ajnr.A3384. Epub 2013 Jan 31.

PMID:
23370479
[PubMed - indexed for MEDLINE]
Free Article
2.

Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?

Fellah S, Caudal D, De Paula AM, Dory-Lautrec P, Figarella-Branger D, Chinot O, Metellus P, Cozzone PJ, Confort-Gouny S, Ghattas B, Callot V, Girard N.

AJNR Am J Neuroradiol. 2013 Jul;34(7):1326-33. doi: 10.3174/ajnr.A3352. Epub 2012 Dec 6.

PMID:
23221948
[PubMed - indexed for MEDLINE]
Free Article
3.

Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.

Chawla S, Oleaga L, Wang S, Krejza J, Wolf RL, Woo JH, O'Rourke DM, Judy KD, Grady MS, Melhem ER, Poptani H.

J Neuroimaging. 2010 Jan;20(1):3-8. doi: 10.1111/j.1552-6569.2008.00307.x.

PMID:
19021846
[PubMed - indexed for MEDLINE]
4.

Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors.

Spampinato MV, Smith JK, Kwock L, Ewend M, Grimme JD, Camacho DL, Castillo M.

AJR Am J Roentgenol. 2007 Jan;188(1):204-12.

PMID:
17179366
[PubMed - indexed for MEDLINE]
5.

Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.

Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH.

Acta Radiol. 2010 Apr;51(3):316-25. doi: 10.3109/02841850903482901.

PMID:
20092374
[PubMed - indexed for MEDLINE]
6.

Proton MR spectroscopy in predicting the increase of perfusion MR imaging for WHO grade II gliomas.

Guillevin R, Menuel C, Abud L, Costalat R, Capelle L, Hoang-Xuan K, Habas C, Chiras J, Vallée JN.

J Magn Reson Imaging. 2012 Mar;35(3):543-50. doi: 10.1002/jmri.22862. Epub 2011 Nov 1.

PMID:
22045581
[PubMed - indexed for MEDLINE]
7.

Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status.

Kapoor GS, Gocke TA, Chawla S, Whitmore RG, Nabavizadeh A, Krejza J, Lopinto J, Plaum J, Maloney-Wilensky E, Poptani H, Melhem ER, Judy KD, O'Rourke DM.

J Neurooncol. 2009 May;92(3):373-86. doi: 10.1007/s11060-009-9880-x. Epub 2009 Apr 9.

PMID:
19357963
[PubMed - indexed for MEDLINE]
8.

Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.

Fink JR, Carr RB, Matsusue E, Iyer RS, Rockhill JK, Haynor DR, Maravilla KR.

J Magn Reson Imaging. 2012 Jan;35(1):56-63. doi: 10.1002/jmri.22801. Epub 2011 Oct 14.

PMID:
22002882
[PubMed - indexed for MEDLINE]
9.

Differentiation of intracranial tuberculomas and high grade gliomas using proton MR spectroscopy and diffusion MR imaging.

Peng J, Ouyang Y, Fang WD, Luo TY, Li YM, Lv FJ, Zhang ZW, Li XY.

Eur J Radiol. 2012 Dec;81(12):4057-63. doi: 10.1016/j.ejrad.2012.06.005. Epub 2012 Jul 1.

PMID:
22749802
[PubMed - indexed for MEDLINE]
10.

Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.

Zonari P, Baraldi P, Crisi G.

Neuroradiology. 2007 Oct;49(10):795-803. Epub 2007 Jul 10.

PMID:
17619871
[PubMed - indexed for MEDLINE]
11.

Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?

Hourani R, Brant LJ, Rizk T, Weingart JD, Barker PB, Horská A.

AJNR Am J Neuroradiol. 2008 Feb;29(2):366-72. Epub 2007 Nov 30.

PMID:
18055564
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.

Emblem KE, Scheie D, Due-Tonnessen P, Nedregaard B, Nome T, Hald JK, Beiske K, Meling TR, Bjornerud A.

AJNR Am J Neuroradiol. 2008 Oct;29(9):1664-70. doi: 10.3174/ajnr.A1182. Epub 2008 Jun 26.

PMID:
18583405
[PubMed - indexed for MEDLINE]
Free Article
13.

Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.

Server A, Kulle B, Gadmar ØB, Josefsen R, Kumar T, Nakstad PH.

Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13.

PMID:
20708868
[PubMed - indexed for MEDLINE]
14.

In vivo differentiation of aerobic brain abscesses and necrotic glioblastomas multiforme using proton MR spectroscopic imaging.

Lai PH, Weng HH, Chen CY, Hsu SS, Ding S, Ko CW, Fu JH, Liang HL, Chen KH.

AJNR Am J Neuroradiol. 2008 Sep;29(8):1511-8. doi: 10.3174/ajnr.A1130. Epub 2008 May 22.

PMID:
18499784
[PubMed - indexed for MEDLINE]
Free Article
15.

Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging.

Whitmore RG, Krejza J, Kapoor GS, Huse J, Woo JH, Bloom S, Lopinto J, Wolf RL, Judy K, Rosenfeld MR, Biegel JA, Melhem ER, O'Rourke DM.

J Neurosurg. 2007 Sep;107(3):600-9.

PMID:
17886561
[PubMed - indexed for MEDLINE]
16.

Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.

Xu M, See SJ, Ng WH, Arul E, Back MF, Yeo TT, Lim CC.

Neurosurgery. 2005 May;56(5):919-26; discussion 919-26.

PMID:
15854239
[PubMed - indexed for MEDLINE]
17.

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.

Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D.

AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98.

PMID:
14625221
[PubMed - indexed for MEDLINE]
Free Article
18.

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

Jenkinson MD, Smith TS, Joyce KA, Fildes D, Broome J, du Plessis DG, Haylock B, Husband DJ, Warnke PC, Walker C.

Neuroradiology. 2006 Oct;48(10):703-13. Epub 2006 Aug 26.

PMID:
16937145
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.

Bobek-Billewicz B, Stasik-Pres G, Majchrzak H, Zarudzki L.

Folia Neuropathol. 2010;48(2):81-92.

PMID:
20602289
[PubMed - indexed for MEDLINE]
20.

Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features.

Jenkinson MD, du Plessis DG, Smith TS, Joyce KA, Warnke PC, Walker C.

Brain. 2006 Jul;129(Pt 7):1884-91. Epub 2006 May 2.

PMID:
16670176
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk